NYTIMES (Dani Blum) - The Thriving Black Market for a Powerful Weight Loss Drug
People are buying what they believe to be retatrutide from WhatsApp groups, Chinese labs and websites selling it “for research purposes.”
NEWSNATIONNOW (Damita Menezes) - Weight loss drug retatrutide use requires strict supervision, doctor says
A doctor's greater concern, she said, is not the drug itself but how patients obtain it.
NEWSNATIONNOW (Zach Kaplan) - Next-gen obesity drug helps patients lose 28% of body weight: Eli Lilly
Eli Lilly can now seek regulatory approval and potentially launch the next-generation drug in 2027.
NYTIMES (Gina Kolata and Rebecca Robbins) - Experimental Drug Yields Dramatic Weight Loss
People who got the injection, retatrutide, lost 28 percent of their body weight on average after 80 weeks, Eli Lilly said.
NYTIMES (Dani Blum) - A New Concern About Weight Loss Drugs: What if They Work Too Well?
Some patients in a clinical trial of one new drug lost so much weight that they became concerned and dropped out.
THENATIONALPULSE (Pulse Wires) - Eli Lilly Invests $3.5 Billion in America for Advanced Obesity Drugs Plant.
PULSE POINTSWHAT HAPPENED: Eli Lilly announced plans to invest over $3.5 billion to build a manufacturing plant in Pennsylvania’s Lehigh Valley to produce next-generation obesity drugs.WHO WAS INVOLVED: Eli Lilly, CEO Dave Ricks, President Donald J. Trump, and rival pharmaceutical company Novo Nordisk.WHEN & WHERE: The announcement was made on Friday, with construction expected to […] The post Eli Lilly Invests $3.5 Billion in America for Advanced Obesity Drugs Plant. appeared first on The National Pulse .
PULSE POINTS WHAT HAPPENED: Eli Lilly announced plans to invest over $3.5 billion to build a manufacturing plant in Pennsylvania’s Lehigh Valley to produce next-generation obesity drugs . WHO WAS INVOLVED: Eli Lilly, CEO Dave Ricks, President Donald J. Trump, and rival pharmaceutical company Novo Nordisk. WHEN & WHERE: The announcement was made on Friday, with construction expected to begin this year in Pennsylvania. The site is projected to be operational by 2031. KEY QUOTE: “Lilly CEO Dave Ricks has told me the drugmaker aims to build six plants in the U.S.” – President Donald Trump IMPACT: The plant will create 850 permanent jobs and 2,000 construction jobs, while advancing production capacity for obesity treatments. IN FULL…Open